(Q39539195)

English

Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects

scientific article published on 23 May 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

acute megakaryoblastic leukemia

1 reference

based on heuristic

inferred from title

Roberto Chiarle

8

object named as

Roberto Chiarle

0 references

Giorgio Inghirami

16

object named as

Giorgio Inghirami

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

object named as

Ludovica Riera

1

0 references

Alberto Bardelli

object named as

Alberto Bardelli

15

0 references

Fabio Facchetti

object named as

Fabio Facchetti

11

0 references

author name string

Elena Lasorsa

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Lisa Bonello

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Francesca Sismondi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Fabrizio Tondat

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Cristiana Di Bello

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Paola Francia Di Celle

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Laura Godio

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Achille Pich

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Maurilio Ponzoni

12

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Filippo Marmont

13

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Carlo Zanon

14

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

23 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1742-1750

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Development of minimal residual disease-directed therapy in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Clinical implications of molecular genetic aberrations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Activating alleles of JAK3 in acute megakaryoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Efficient tumour formation by single human melanoma cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Engraftment of NOD/SCID/gammac(null) mice with multilineage neoplastic cells from patients with juvenile myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Mouse modeling in oncologic preclinical and translational research

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

STAT5 signaling is required for the efficient induction and maintenance of CML in mice

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Activating mutations in human acute megakaryoblastic leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

JAK mutations in high-risk childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

The Tyrosine Phosphatase Shp2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.574757

21 January 2018

Identifiers

10.3109/10428194.2011.574757

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39539195&oldid=1836863202"